Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Dose-Response Study to Assess the Efficacy and Safety of AQUAVAN® Injection for Procedural Sedation in Patients Undergoing Colonoscopy

NCT00125424 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00125424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00125424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Dose-Response Study to Assess the Efficacy and Safety of AQUAVAN® Injection for Procedural Sedation in Patients Undergoing Colonoscopy
Lead sponsor
Eisai Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2005
Completion date
September 30, 2005
Enrollment
125
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

colonic polyps, colonoscopy